Small Molecules

05 Jun 2007 Single-Agent SUTENT Prolonged Progression-Free Survival across All Advanced Kidney Cancer Patient Risk Groups, Including Those with Poorest Prognoses, Data Show
05 Jun 2007 Cardiome and Astellas Announce Positive Results from ACT 2 Trial
05 Jun 2007 Evotec Reports Positive Proof-of-Concept Top-Line Results with Insomnia Drug Candidate EVT 201
05 Jun 2007 Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an Important Treatment Option for Patients With Metastatic Colorectal Cancer
05 Jun 2007 New Data Show Pfizer's Axitinib Prolonged Overall Survival in Advanced Pancreatic Cancer When Combined with Standard of Care Chemotherapy
05 Jun 2007 Cytokinetics Announces the Presentation of Clinical Trials Data at the 2007 Annual Meeting of the American Society of Clinical Oncology
05 Jun 2007 Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in Phase 2 Trial
05 Jun 2007 GW Commences Phase I Study of THCV, a Potential Treatment for Obesity and Related Metabolic Disorders
05 Jun 2007 Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
05 Jun 2007 Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
05 Jun 2007 Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
05 Jun 2007 NPS Announces Progression of the Calcilytics Development Program in Osteoporosis by GlaxoSmithKline
05 Jun 2007 ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
04 Jun 2007 Tapestry Pharmaceuticals presents Phase I data on TPI 287 at the 43rd ASCO Annual Meeting
04 Jun 2007 Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
04 Jun 2007 Vical Demonstrates Safety and Tolerability of IL-2 DNA Delivery with Electroporation
04 Jun 2007 ARIAD Presents Positive Efficacy Data On AP23573, Novel mTOR Inhibitor, in Phase 2 Metastatic Endometrial Cancer Trial
04 Jun 2007 Positive data from ASA404 prostate cancer trial presented at ASCO
04 Jun 2007 Millennium Introduces New Oncology Molecule with Activity in Broad Range of Cancer Models
03 Jun 2007 ABRAXANE Demonstrates Longer Progression-Free Survival versus Taxotere in the Treatment of First-Line Metastatic Breast Cancer
03 Jun 2007 INNOVIVE Pharmaceuticals Presents Additional Phase I Data on INNO-406 for Treatment of Gleevec-Resistant or Intolerant Chronic Myelogenous Leukemia at the American Society of Clinical Oncology Annual Meeting
03 Jun 2007 Cyclacel reports Phase I sapacitabine data in patients with advanced leukemias and myelodysplastic syndromes at 2007 ASCO
03 Jun 2007 Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
03 Jun 2007 Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer
03 Jun 2007 Exelixis Reports Comprehensive XL880 Phase I Data At ASCO

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up